Journal of Clinical Medicine of Kazakhstan (ISSN 1812-2892) is a multi-field dedicated peer-reviewed medical journal. The main thematic scope is the publication of research materials in the area of biomedical science and practice, medical education, and public health. The Journal of Clinical Medicine of Kazakhstan is designed to increase the depth of the object in these areas, with the ultimate aim of expanding knowledge of the subject. We encourage researchers worldwide for contributing and presenting manuscripts with an online system www.clinmedkaz.org in the English language.


JSC “National Scientific Medical Research Center” is the owner and publisher of the journal. This journal publishes bimonthly in a year (in February, April, June, August, October, and December). All of the expenses related to editorial and publishing processes covered by the JSC National Scientific Medical Research Center.


The Journal of Clinical Medicine of Kazakhstan encourages the provision of material from authors all over the world. All manuscripts if found suitable will undergo the double-blind peer-review process. Manuscripts will be judged at least by two experts exclusively based on their contribution to initial data, ideas, and their scientific fields. All articles should correspond with instructions for authors.

Following articles will be considered for publication:

  • Editorial articles,
  • Review articles,
  • Original articles,
  • Case reports,
  • Short communications,
  • Letters to the editor.

Submitted new manuscripts must not have been published, accepted for publication, or be under consideration elsewhere. Authors must submit their manuscripts via an online submission system according to journal requirements. Manuscripts submitted/sent by email or by postal mail will not be considered. All articles submitted to the Journal must comply with these instructions. Failure to do so will result in a return of the manuscript and a possible delay in publication. Detailed information, “how-to submit manuscript” is available in the section Instruction for authors.

Plagiarism screening: All received manuscripts are subject to plagiarism screening by iThenticate software.  We will allow only 15-20% similarity, however, the verbatim copies of strings of text at the sentence, paragraph, or section level are not allowed. If the similarity score is above the 20%, the editor may investigate the plagiarism report and give feedback to authors with a request for adjustments.

First decision: All articles will be strictly considered by the editor(s) and members of the editorial board for 6-8 weeks, but sometimes there can be long delays. Authors can refer to resources of information according to standard requirements for publications, presented in biomedical journals, prepared by the International Committee of Medical Journal Editors.

Submission of revised manuscripts: While submitting a revised manuscript, contributors are requested to include a point-to-point response to the reviewer's comments at the beginning of the revised manuscript text file itself. In addition, if any changes are made to the manuscript, please mark the changes as underlined or differently colored text in the article.

Page proofs: Page proofs of the manuscript, a form for marking corrections, and instructions for filling the form will be sent to the corresponding author by e-mail, before the publication of the manuscript. Authors should type the proof corrections in the form and send it to the Editorial Office. While checking the proofs, take note that the text is complete and all figures and tables are included in the proofs. Respond to all queries from the Editorial Office; check the proofs for changes like spellings, punctuation, and setting of the text, tables, figures, and figure legends. Corrected proofs must be returned to the Editorial office within 72 hrs (3 days) of receipt. The page proofs can be sent to the Editorial Office by uploading through our website or as email attachments with indicated manuscript ID.

Article processing charges (APCs)

Journal of Clinical Medicine of Kazakhstan currently does not charge the submission fee, membership fee, publication fee, page fee, color figure fee, or any other APCs for regular paper submissions. All of the submitted manuscripts are reviewed and published free of charge.


Journal of Clinical Medicine of Kazakhstan is fully committed to the Open Access Initiative and will provide free access to the full text of all articles as soon as they are published and available from journal websites as PDF and HTML versions. All published articles have titles and abstracts in English regardless of the article's main language. HTML versions of articles provided with built-in Google Translate widgets, thus, full text and all content of articles can be easily translated to any language, selected by readers.

Creative Commons License This journal and published articles are licensed under the CC-BY Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Copyright and Permissions

The copyrights of articles accepted for publication before 2016 belong to the journal. The copyrights of articles accepted for publication after 2016 (volume 1, number 39, issue 2016) belong to their authors. Journal allows the author(s) to hold the copyright without restrictions. Also, authors continue to hold the copyrights of their own papers by acknowledging that their papers are originally published in the Journal of Clinical Medicine of Kazakhstan. Hence, articles published are licensed under the CC-BY Creative Commons Attribution 4.0 International License.

Advertising Policy

Journal of Clinical Medicine of Kazakhstan accepts advertising only for hard copies of printed issues and journal webpage according to the following principles:

  • Advertising must be separate from content. Content may not be altered, added, or deleted to accommodate advertising. Advertisers have no input regarding any of our editorial decisions or advertising policies. The advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published.
  • Journal of Clinical Medicine of Kazakhstan reserves the right to decline or cancel any advertisement at any time.
  • Third-party advertisements may not use JCMK name, logo, or title on their web pages or email alerts.
  • Advertised products must be compliant with the regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products (including new drug applications) that are subject to U.S. Food and Drug Administration oversight must comply with FDA regulations regarding advertising and promotion.
  • Advertisers have no control or influence over the results of searches a user may conduct on Journal web pages.


The Journal of Clinical Medicine of Kazakhstan was founded in 2004 by National Scientific Medical Research Center (Astana, Kazakhstan) and registered by the Ministry of Information of the Republic of Kazakhstan at 05.04.2004 and indexed in the list of scientific journals, approved by the Committee for Control of Education and Science, Ministry of Education and Science of the Republic of Kazakhstan for publication of scientific study results.

Until 2013, editorial and publishing processes were provided via paper-based submission of "hard copy", and all published issues were deposited only in national and local libraries. Begining from 2013 years (volume 4, number 30, issue 2013), editorial and publishing processes have been transferred to an electronic double-blind peer review editorial submission system. After that, all accepted manuscripts, regular and special issues available in the archive of the journal website. Some earliest issues of the journal also available at the website of Russian Science Citation Index and Cyberleninka.

Beginning from 2016 (volume 1, number 39, issue 2016) Journal of Clinical Medicine of Kazakhstan became the member of The Publishers International Linking Association, Inc. (“PILA”) and all regular issues and some special issues (peer-reviewed special issues with full texts) of the journal started to deposit in CrossRef with DOI numbers.

Beginning from 2020, the journal publishes bimonthly (6 issues per year), only in English.


JSC National Scientific Medical Research Center

Ave Abylay-khan #42, Postal code 010009, Astana, Kazakhstan
Tel: +7 (7172) 577 411
Fax: +7 (7172) 23 29 27
Website: www.nnmc.kz
E-mail: national_clinic@nnmc.kz

If you have any questions about your submitted papers, please kindly indicate the manuscript ID number and the manuscript title in your correspondence and send your inquiries to Editorial e-mail: editor@clinmedkaz.org

If you have any questions about your accepted papers, please kindly indicate the manuscript ID number and the manuscript title in your correspondence and send your inquiries to Production e-mail: production@clinmedkaz.org